Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 9104 | 1121 | 36.7 | 70% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | POSITIVE BONE BALANCE | Author keyword | 3 | 100% | 0% | 3 |
| 2 | PROSTAGLANDIN ESTRADIOL PGE2 | Author keyword | 3 | 100% | 0% | 3 |
| 3 | ENDOCRINOL METAB MC1850 | Address | 2 | 67% | 0% | 2 |
| 4 | HLTH MED ENDOCRINOL METAB | Address | 2 | 67% | 0% | 2 |
| 5 | ANTIGENIC PHENOTYPE | Author keyword | 2 | 36% | 0% | 4 |
| 6 | CORTICAL HYPEROSTOSIS | Author keyword | 2 | 36% | 0% | 4 |
| 7 | EP4 RECEPTOR | Author keyword | 2 | 14% | 1% | 11 |
| 8 | BIOMED GRP BIO277 | Address | 1 | 38% | 0% | 3 |
| 9 | MINERALIZED BONE NODULE | Author keyword | 1 | 50% | 0% | 2 |
| 10 | PGE RECEPTOR SUBTYPES | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | METAPHYSEAL HARD TISSUE | 67 | 76% | 4% | 47 |
| 2 | RAPIDLY GROWING RATS | 45 | 80% | 2% | 28 |
| 3 | FRACTURED RIBS | 18 | 89% | 1% | 8 |
| 4 | ADDS BONE | 8 | 100% | 0% | 5 |
| 5 | E RECEPTOR SUBTYPES | 7 | 43% | 1% | 13 |
| 6 | CULTURED MOUSE CALVARIA | 5 | 45% | 1% | 9 |
| 7 | CLONE MC3T3 E1 CELLS | 5 | 63% | 0% | 5 |
| 8 | CONTROLLED RELEASE PELLETS | 5 | 50% | 1% | 7 |
| 9 | MOUSE CALVARIAL BONES | 5 | 50% | 1% | 7 |
| 10 | ANTIGENIC PHENOTYPE | 5 | 44% | 1% | 8 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Prostaglandins in bone: bad cop, good cop? | 2010 | 70 | 71 | 48% |
| NSAIDs and fracture healing | 2013 | 10 | 75 | 69% |
| Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process | 2008 | 50 | 51 | 65% |
| Do Nonsteroidal Anti-Inflammatory Drugs Affect Bone Healing? A Critical Analysis | 2012 | 20 | 128 | 66% |
| The in vivo anabolic actions of prostaglandins in bone | 1997 | 122 | 54 | 65% |
| Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing? | 2009 | 29 | 72 | 60% |
| The Effect of Nonsteroidal Anti-Inflammatory Drug Administration on Acute Phase Fracture-Healing: A Review | 2012 | 13 | 60 | 65% |
| Prostaglandin E-2 receptors in bone formation | 2007 | 29 | 22 | 77% |
| NSAID therapy effects on healing of bone, tendon, and the enthesis | 2013 | 7 | 93 | 42% |
| Non-steroidal anti-inflammatory drugs inhibit bone healing: A review | 2010 | 10 | 55 | 78% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ENDOCRINOL METAB MC1850 | 2 | 67% | 0.2% | 2 |
| 2 | HLTH MED ENDOCRINOL METAB | 2 | 67% | 0.2% | 2 |
| 3 | BIOMED GRP BIO277 | 1 | 38% | 0.3% | 3 |
| 4 | PHARMACEUT CHEM ORGAN CHEM | 1 | 50% | 0.2% | 2 |
| 5 | PHARMOTA KU | 1 | 50% | 0.2% | 2 |
| 6 | MOTHER CHILD MED | 1 | 40% | 0.2% | 2 |
| 7 | BIOCHEM ORIENTAL MED | 1 | 50% | 0.1% | 1 |
| 8 | BONE METAB REPAIRTRAUMA SURG | 1 | 50% | 0.1% | 1 |
| 9 | CHUG HO MEM HOSP | 1 | 50% | 0.1% | 1 |
| 10 | CIENCIAS MED SAUDE SOROCABA | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000247365 | LIPID CHEM MOL BIOL//ENHANCING FOODS PROTECT HLTH//BONE BIOMECHANICAL STRENGTH |
| 2 | 0.0000241633 | LONGEV SCI//HOSP GERIATR MED//TORAT MED |
| 3 | 0.0000213174 | PERIODONTAL DISEASE ETIOLOGY//FRONTIER BIOMED SCI//INFLAMMATORY PERIODONTITIS |
| 4 | 0.0000104231 | GROWTH HORMONE BIOL//IN SITU SETTING CEMENT//POLYD L LACTIDE COATING |
| 5 | 0.0000100767 | MARROW FIBROBLASTS//OSTEOPROGENITORS//OSTEOBLASTIC MARKERS |
| 6 | 0.0000085068 | OSTEOPOROSIS INDUCTION//CHAIR SURG PATHOPHYSIOL//OST 6 OSTEOCARE |
| 7 | 0.0000078980 | ONO 1301//IP RECEPTOR//EP4 RECEPTOR |
| 8 | 0.0000075892 | RANKL//OSTEOCLAST//OSTEOCLASTOGENESIS |
| 9 | 0.0000072148 | MU MSV//CLA PTX//EPIDERMIS PROLIFERATION |
| 10 | 0.0000070507 | TERIPARATIDE//PTH//REG BONE |